# A Study of GC1111 in Hunter Syndrom Patients

> **NCT03920540** · PHASE3 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 32 (actual)

## Conditions studied

- Hunter Syndrome

## Interventions

- **COMBINATION_PRODUCT:** GC1111
- **COMBINATION_PRODUCT:** Comparator

## Key facts

- **NCT ID:** NCT03920540
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-02-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03920540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03920540, "A Study of GC1111 in Hunter Syndrom Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03920540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*